Acasti Pharma Inc.
ACST
Kedudukan dalam Saham
#29737
Acasti Pharma Inc. is a biopharmaceutical company dedicated to the research,... Acasti Pharma Inc. is a biopharmaceutical company dedicated to the research, development, and market introduction of pharmaceutical solutions for cardiovascular conditions. The firm is currently exploring strategic collaborations to further the clinical advancement of its compound, CaPre. Established in 2002, Acasti Pharma Inc. maintains its principal operations from its headquarters in Laval, Canada.
Harga Saham
$0.4256834
Disegerakkan terakhir: 2023-03-27
Modal Pasaran
$18.99M
Perubahan (1 hari)
3.08%
Perubahan (1 tahun)
-87.02%
Negara
CA
Perdagangan Acasti Pharma Inc. (ACST)
Kategori
Healthcare
Nisbah P/B bagi Acasti Pharma Inc. (ACST)
Nisbah P/B pada October 2026 TTM: 1.21
Menurut laporan kewangan dan harga saham terkini Acasti Pharma Inc., nisbah P/B semasa (TTM) ialah 1.21. Pada akhir 2024, nisbah P/B syarikat ialah 0.36.
Sejarah nisbah P/B untuk Acasti Pharma Inc. dari 2010 hingga 2026
Nisbah P/B pada akhir setiap tahun
| Tahun | Nisbah P/B | Ubah |
|---|---|---|
| 2026 (TTM) | 1.21 | 194.44% |
| 2025 | 0.41 | 14.12% |
| 2024 | 0.36 | 10.08% |
| 2023 | 0.33 | 92.91% |
| 2022 | 0.17 | 27.77% |
| 2021 | 0.13 | -67.27% |
| 2020 | 0.41 | -0.78% |
| 2019 | 0.41 | 85.32% |
| 2018 | 0.22 | 0.00% |
| 2017 | 0.00 | -100.00% |
| 2016 | 0.05 | 43.77% |
| 2015 | 0.03 | 59.69% |
| 2014 | 0.02 | -60.40% |
| 2013 | 0.05 | 72.47% |
| 2012 | 0.03 | -46.46% |
| 2011 | 0.05 | 52.71% |
| 2010 | 0.04 | 0.00% |
Nisbah P/B untuk syarikat atau pesaing yang serupa
| Syarikat | Nisbah P/B | Perbezaan Nisbah P/B | Negara |
|---|---|---|---|
| 6.251 | 417.81% |
US
|
|
| 13.2547 | 997.97% |
US
|
|
| 4.208 | 248.58% |
AU
|
|
| - | - |
CH
|
|
| 6.1824 | 412.13% |
NL
|
